AstraZeneca's stock falls 3% as results from early-stage study on ...
Pluralism / Jul 20, 2020 - Source: marketwatch
Shares of AstraZeneca undefinedundefined were down 3.4% in trading on Monday after a medical journal published a study that found the company's ...
Most popular of marketwatch
- How can companies atone for slavery ties? Financial giant sets an ...
- Intel stock savaged as next-gen chip delay expected to be ...
- Dow on pace to snap win streak, even as tech-heavy Nasdaq ...
- Dow books modest loss after touching record, Nasdaq Composite ...
- CenturyLink experiences internet-service outages around the country
- Billionaire David Tepper says stock market tumbled too sharply Monday — so ...
- Some Wells Fargo ATMs, online banking down after data-center problem
- The Ring doorbell is already one of Amazon Prime Day's hottest deals
- Frantic evacuations and rescues as fast-moving fire destroys homes ...
- Warriors cop to complacency as malaise continues in second home loss to Clippers
- 10 First Day Of Spring 2019 Memes That Are Relatable & Funny
- (Video): 22 Details In The ‘Game Of Thrones’ Finale You Might Have Missed
- Bianca Devins' mom glad killer pleaded guilty, but says she will ...
- Ravi Zacharias receives grim prognosis on cancer battle - chvnradio ...
- (Video):Welcome to my OG Skin Fortnite Clan (RARE Skins Only)
- (Video): VIBE CHECK VIBE CHECK VIBE CHECK VIBE CHECK VIBE CHECK
Best of the week
Recent posts
Twitter Trends Us
2. Ladd McConkey
3. Chargers
4. Patriots
5. Justin Herbert
6. #BoltUp
7. Pats
8. Polk
9. UConn
10. #LACvsNE